11-108308003-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_000051.4(ATM):c.5762+19C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000101 in 1,588,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.000013   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.0000098   (  0   hom.  ) 
Consequence
 ATM
NM_000051.4 intron
NM_000051.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.345  
Publications
0 publications found 
Genes affected
 ATM  (HGNC:795):  (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010] 
ATM Gene-Disease associations (from GenCC):
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
 - ataxia telangiectasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Laboratory for Molecular Medicine, Orphanet
 - hereditary nonpolyposis colon cancerInheritance: AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
 - prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
 - sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
 - familial ovarian cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
 - gastric carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67). 
BP6
Variant 11-108308003-C-T is Benign according to our data. Variant chr11-108308003-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 490623.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| ATM | NM_000051.4  | c.5762+19C>T | intron_variant | Intron 38 of 62 | ENST00000675843.1 | NP_000042.3 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000131  AC: 2AN: 152142Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
2
AN: 
152142
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.00000975  AC: 14AN: 1435862Hom.:  0  Cov.: 28 AF XY:  0.00000838  AC XY: 6AN XY: 715662 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
14
AN: 
1435862
Hom.: 
Cov.: 
28
 AF XY: 
AC XY: 
6
AN XY: 
715662
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
32876
American (AMR) 
 AF: 
AC: 
0
AN: 
44618
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
25992
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39470
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
85590
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53208
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5728
European-Non Finnish (NFE) 
 AF: 
AC: 
14
AN: 
1088826
Other (OTH) 
 AF: 
AC: 
0
AN: 
59554
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.475 
Heterozygous variant carriers
 0 
 1 
 2 
 2 
 3 
 4 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0000131  AC: 2AN: 152142Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74308 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
2
AN: 
152142
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
1
AN XY: 
74308
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41434
American (AMR) 
 AF: 
AC: 
0
AN: 
15270
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5198
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10602
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
68026
Other (OTH) 
 AF: 
AC: 
0
AN: 
2094
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.425 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
Ataxia-telangiectasia syndrome    Benign:1 
Dec 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hereditary cancer-predisposing syndrome    Benign:1 
May 22, 2017
Color Diagnostics, LLC DBA Color Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.